Melinta Therapeutics Announces Appointment of Jennifer Sanfilippo to...

09/03/19

Melinta Therapeutics Announces Appointment of Jennifer Sanfilippo to Interim Chief Executive Officer and Director  Nasdaq

MORRISTOWN, N.J., Sept. 03, 2019-- Melinta Therapeutics, Inc., a commercial-stage company focused on the development and commercialization of novel.

[more]